Dermapharm Holding SE (LTS:0A5J) Other Operating Expense : €552 Mil (TTM As of Dec. 2024)

View and export this data going back to 2020. Start your Free Trial

What is Dermapharm Holding SE Other Operating Expense?

Dermapharm Holding SE's Other Operating Expense for the three months ended in Dec. 2024 was €148 Mil. Its Other Operating Expense for the trailing twelve months (TTM) ended in Dec. 2024 was €552 Mil.

Dermapharm Holding SE's quarterly Other Operating Expense declined from Jun. 2024 (€141 Mil) to Sep. 2024 (€130 Mil) but then increased from Sep. 2024 (€130 Mil) to Dec. 2024 (€148 Mil).

Dermapharm Holding SE's annual Other Operating Expense increased from Dec. 2022 (€339 Mil) to Dec. 2023 (€433 Mil) and increased from Dec. 2023 (€433 Mil) to Dec. 2024 (€452 Mil).

Dermapharm Holding SE Other Operating Expense Historical Data

The historical data trend for Dermapharm Holding SE's Other Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Dermapharm Holding SE Other Operating Expense Chart

Dermapharm Holding SE Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Other Operating Expense

Get a 7-Day Free Trial

238.94

253.60

338.86

433.15

452.43

Dermapharm Holding SE Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Other Operating Expense	Get a 7-Day Free Trial															141.23	133.51	141.07	130.23	147.52

Dermapharm Holding SE Other Operating Expense Calculation

GuruFocus uses a standardized financial statement format for all companies. For non-financial companies, GuruFocus lists Selling, General, & Admin. Expense, , Research & Development, and Other Operating Expense under the "Total Operating Expense" section.

Other Operating Expense sometimes includes:
Restructuring, and merger
Acquisition related and other
Litigation settlement charge
Other (too numerous to list)

Some companies can and do choose to report each of these items separately. Yet, there are a variety of Other Operating Expense which are simply too numerous to list.

Other Operating Expense for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €552 Mil.

Dermapharm Holding SE Other Operating Expense Related Terms

Thank you for viewing the detailed overview of Dermapharm Holding SE's Other Operating Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

Dermapharm Holding SE Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Dermapharm Holding SE (LTS:0A5J) » Definitions » Other Operating Expense

Traded in Other Exchanges

DMPHF:USA DMPd:UK DMP:Germany

Address

Lil-Dagover-Ring 7, Grunwald, BY, DEU, 82031

Website

https://www.dermapharm.com

Dermapharm Holding SE manufactures patent-free branded pharmaceuticals for selected therapy fields, over-the-counter drugs, and natural remedies. The portfolio of the company includes cosmetics, nutritional supplements, and diet and medical devices. Business operating segments include Branded pharmaceuticals, which drive key revenue, Other healthcare products, and Parallel import business. The Branded pharmaceuticals segment covers numerous product areas through a wide variety of items sold under reputable brand names.

Dermapharm Holding SE Headlines

No Headlines